Trials / Active Not Recruiting
Active Not RecruitingNCT05653765
Prognostic Value of the AMR Measured After PPCI in STEMI Patients
Prognostic Value of the Angio-based Microvascular Resistance Use One Single Angiographic View Measured After Primary Percutaneous Coronary Intervention in ST-segment Elevation Myocardial Infarction Patients
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,663 (actual)
- Sponsor
- Henan Institute of Cardiovascular Epidemiology · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this observational study is to learn about in STEMI with Primary PCI Patients. The main questions it aims to answer are: * To determine the value of AMR in predicting the long-term clinical prognosis of patients with STEMI after PPCI, and to find the best cut-off value. * Analyze the factors of PPCI affecting AMR and explore the effective measures of PPCI microcirculation protection. Radiographic images of STEMI receiving primary PCI treatment in several chest pain centers in China will be included. The last image of the infarct-related vessel will be used as a target to calculate its AMR. The relationship between AMR and long-term clinical prognosis was analyzed.
Conditions
Timeline
- Start date
- 2022-12-20
- Primary completion
- 2023-12-20
- Completion
- 2025-03-20
- First posted
- 2022-12-16
- Last updated
- 2025-03-17
Locations
5 sites across 1 country: China
Source: ClinicalTrials.gov record NCT05653765. Inclusion in this directory is not an endorsement.